Abstract
We investigated the association of the NRG1 gene and schizophrenia using meta-analytic techniques, combining all published data while restricting our analysis to studies investigating the most commonly reported single marker (SNP8NRG221533). We also investigated whether ancestry (European vs East Asian) and study design (family-based vs case–control) moderated any association. We found no evidence for an association of SNP8NRG221533 with schizophrenia, and significant between-study heterogeneity, which persisted when family-based studies were combined separately. However, when haplotype-based P-values were combined, there was evidence in support of an association of NRG1 with schizophrenia, and no evidence of between-study heterogeneity. Our meta-analysis provides support for the association of NRG1 with schizophrenia, but indicates that firmly establishing the role of NRG1 gene in schizophrenia by genetic association requires much larger sample sizes than have hitherto been reported. Association analyses and replications should take place at the level of the gene, rather than at the level of SNP, haplotype, or functional variant. Meta-analysis would then be carried out on the basis of the combination of P-values.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rossler W, Salize HJ, van Os J, Riecher-Rossler A . Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 2005; 15: 399–409.
Owen MJ, Williams NM, O'Donovan MC . The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 9: 14–27.
Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337–348.
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–892.
Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675–13680.
Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373–1380.
Glatt SJ, Faraone SV, Tsuang MT . Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case–control and family-based studies. Am J Psychiatry 2003; 160: 469–476.
Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99: 3717–3722.
Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004; 101: 12604–12609.
Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA . Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131–137.
Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423.
Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40–68; image 5.
Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73: 1438–1443.
Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8: 485–487.
Munafo MR, Bowes L, Clark TG, Flint J . Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies. Mol Psychiatry 2005; 10: 765–770.
Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 2005; 10: 366–374, 328.
Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83–87.
Thiselton DL, Webb BT, Neale BM, Ribble RC, O'Neill FA, Walsh D et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry 2004; 9: 777–783, ; image 729.
Iwata N, Suzuki T, Ikeda M, Kitajima T, Yamanouchi Y, Inada T et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol Psychiatry 2004; 9: 126–127.
Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N et al. A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet 2004; 41: 31–34.
Tang JX, Chen WY, He G, Zhou J, Gu NF, Feng GY et al. Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 2004; 9: 11–12.
Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J et al. Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9: 208–213.
Morris DW, McGhee K, Schwaiger S, Nangle J, Murphy K, Donohoe G et al. An update of association studies of DTNBP1, NRG1, RGS4 and MRDS1 in an extended Irish schizophrenia case–control sample. Am J Med Genet 2004; 130B: 143.
Hall D, Gogos JA, Karayiorgou M . The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 2004; 3: 240–248.
Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 2003; 8: 706–709.
Hong CJ, Huo SJ, Liao DL, Lee K, Wu JY, Tsai SJ . Case–control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neurosci Lett 2004; 366: 158–161.
Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM et al. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry 2004; 9: 698–704.
Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ et al. Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry 2004; 9: 1061–1063.
Neale BM, Sham PC . The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75: 353–362.
Kazeem GR, Farrall M . Integrating case-control and TDT studies. Ann Hum Genet 2005; 69 (Part 3): 329–335.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, Ioannidis JP . Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet 2004; 12: 762–769.
Hayashino Y, Noguchi Y, Fukui T . Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 2005; 15: 235–243.
Darlington RB, Hayes AF . Combining independent P-values: extensions of the Stouffer and binomial methods. Psychol Methods 2000; 5: 496–515.
Fukui N, Muratake T, Kaneko N, Amagane H, Someya T . Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. Neurosci Lett 2005 (Epub ahead of print).
Lachman HM, Pedrosa E, Nolan KA, Glass M, Ye K, Saito T . analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 102–109.
Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG, Chen WJ . Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents. Psychol Med 2005; 35: 1589–1598.
Duan J, Martinez M, Sanders AR, Hou C, Krasner AJ, Schwartz DB et al. Neuregulin 1 (NRG1) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychol Med 2005; 35: 1599–1610.
Gardner M, Gonzalez-Neira A, Lao O, Calafell F, Bertranpetit J, Comas D . Extreme population differences across Neuregulin 1 gene, with implications for association studies. Mol Psychiatry 2006; 11: 66–75.
Owen MJ, Craddock N, O'Donovan MC . Schizophrenia: genes at last? Trends Genet 2005; 21: 518–525.
Fisher RA . Statistical Methods for Research Workers. Oliver and Boyd: Edinburgh, 1925.
Acknowledgements
Dawn Thiselton is an Essel Foundation NARSAD Young Investigator. Jonathan Flint is supported by the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Munafò, M., Thiselton, D., Clark, T. et al. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11, 539–546 (2006). https://doi.org/10.1038/sj.mp.4001817
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001817
Keywords
This article is cited by
-
Identification of novel biomarkers linking depressive disorder and Alzheimer’s disease based on an integrative bioinformatics analysis
BMC Genomic Data (2023)
-
Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models
Molecular Psychiatry (2018)
-
Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia
Translational Psychiatry (2017)
-
Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling
Scientific Reports (2016)
-
Sensory encoding in Neuregulin 1 mutants
Brain Structure and Function (2016)